Aesthetic Medical International Holdings Group Ltd (AIH) FinancialsAIHAesthetic Medical International Holdings Group Ltd

Aesthetic Medical International Holdings Group Ltd (AIH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Non-surgical aesthetic medical services, accounting for 60.4% of total sales, equivalent to CNY 143.67M. Other significant revenue streams include Surgical aesthetic medical services and General healthcare services and other aesthetic medical services. Understanding this composition is critical for investors evaluating how AIH navigates market cycles within the Healthcare Facilities & Services industry.

Evaluating the bottom line, Aesthetic Medical International Holdings Group Ltd maintains a gross margin of 43.90%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -4.28%, while the net margin is -6.17%. These profitability ratios, combined with a Return on Equity (ROE) of -131.31%, provide a clear picture of how effectively AIH converts its operational activities into shareholder value.